Living with Hereditary Cancer Risk - Steligo, Kathy;Friedman, Sue;Kurian, Allison W.
19,99 €
inkl. MwSt.

Sofort lieferbar
payback
10 °P sammeln
  • Broschiertes Buch

An ideal resource for genetic counselors, physicians, nurses, advocates, and others who support and care for the hereditary cancer community, Living with Hereditary Cancer Risk provides coverage of; signs of inherited cancer risk in a family;; the value of genetic counseling and testing;; mutations in BRCA, Lynch Syndrome, and other genes that elevate cancer risk;; risk-reducing strategies;; traditional treatments and newer personalized approaches, including immunotherapies and PARP inhibitors;; nationally recommended guidelines for prevention, early detection, and treatment;; insurance…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
An ideal resource for genetic counselors, physicians, nurses, advocates, and others who support and care for the hereditary cancer community, Living with Hereditary Cancer Risk provides coverage of; signs of inherited cancer risk in a family;; the value of genetic counseling and testing;; mutations in BRCA, Lynch Syndrome, and other genes that elevate cancer risk;; risk-reducing strategies;; traditional treatments and newer personalized approaches, including immunotherapies and PARP inhibitors;; nationally recommended guidelines for prevention, early detection, and treatment;; insurance coverage and discrimination protections; and; coping with sexual health, fertility, menopause, and other quality of life issues.
Autorenporträt
Kathy Steligo (SAN CARLOS, CA) is the author of The Breast Reconstruction Guidebook and the coauthor of Confronting Chronic Pain and The Breast Cancer Book. She is a two-time breast cancer survivor. Sue Friedman, DVM (GULFPORT, FL), the founder and executive director of Facing Our Risk of Cancer Empowered (FORCE), is a breast cancer survivor with a BRCA2 mutation. Allison W. Kurian, MD, MSc (STANFORD, CA) is a clinical oncologist and the director of the Stanford Women's Clinical Cancer Genetics Program.